Big Clinical Data Analysis of Intravenous to Oral Conversions of Non-Antimicrobials
Advantages of early intravenous(IV)to oral(PO)switches of antimicrobials are well known.Yet,little data have been published on reasonable IV-to-PO switches of other drug classes,although interventions to promote early IV-to-PO conversions may further increase patient safety and decrease costs.We therefore analyzed IV-to-PO switches of non-antimicrobials.
Administration,Intravenous Pharmacoepidemiology
Patrick E.Beeler David W.Bates Jürg Blaser
Research Center for Medical Informatics,University Hospital Zurich & University of Zurich,Switzerlan Division of General Internal Medicine,Brigham and Womens Hospital & Harvard Medical School,Boston,M Research Center for Medical Informatics,University Hospital Zurich & University of Zurich,Switzerlan
国际会议
第十六届世界医药健康信息学大会((MEDINFO2017)、第二届世界医药健康信息学华语论坛(WCHIS 2017)、第15届全国医药信息学大会(CMIA 2017)
苏州
英文
1251-1251
2017-08-21(万方平台首次上网日期,不代表论文的发表时间)